相似文献
1
Effect of methotrexate concentration and exposure time on mammalian cell survival in vitro.
Br J Cancer. 1980 Feb;41(2):277-84. doi: 10.1038/bjc.1980.40.
2
Dependence of the cytostatic effect of adriamycin on drug concenration and exposure time in vitro.
Br J Cancer. 1980 Jun;41(6):886-91. doi: 10.1038/bjc.1980.165.
3
4
Methotrexate cytotoxicity for L5178Y/Asn- lymphoblasts: relationship of dose and duration of exposure to tumor cell viability.
Cancer Res. 1982 May;42(5):1641-5.
5
Reversal of resistance to methotrexate by hyperthermia in Chinese hamster ovary cells.
Cancer Res. 1981 Oct;41(10):3840-3.
6
The relationship between cisplatin sensitivity and drug uptake into mammalian cells in vitro.
Br J Cancer. 1986 Aug;54(2):239-43. doi: 10.1038/bjc.1986.168.
7
8
[Effect of methotrexate (MTX) on neoplastic (HeLa line) and normal (lymphocyte) cells].
Rev Esp Oncol. 1982;29(4):649-64.
9
Resistance of resting 3T6 mouse fibroblasts to methotrexate cytotoxicity.
Cancer Res. 1978 Aug;38(8):2408-12.
10
Collateral sensitivity to methotrexate in cells resistant to adriamycin.
Cancer Res. 1979 Jun;39(6 Pt 1):1937-42.
引用本文的文献
1
A slow-release methotrexate formulation for intrathecal chemotherapy.
Cancer Chemother Pharmacol. 1993;32(3):179-82. doi: 10.1007/BF00685832.
2
An extended-release formulation of methotrexate for subcutaneous administration.
Cancer Chemother Pharmacol. 1994;33(4):303-6. doi: 10.1007/BF00685904.
3
Dependence of the cytostatic effect of adriamycin on drug concenration and exposure time in vitro.
Br J Cancer. 1980 Jun;41(6):886-91. doi: 10.1038/bjc.1980.165.
4
Long-duration intracavitary infusion of methotrexate with systemic leucovorin protection in patients with malignant effusions.
J Clin Invest. 1981 Apr;67(4):1161-70. doi: 10.1172/jci110130.
5
Quantitation of chemosensitivity in acute myelocytic leukaemia.
Br J Cancer. 1983 Oct;48(4):559-67. doi: 10.1038/bjc.1983.229.
6
Comparison of serum and cerebrospinal fluid levels of methotrexate in man during high-dose chemotherapy for aggressive non-Hodgkin's lymphoma.
Cancer Chemother Pharmacol. 1985;15(3):290-4. doi: 10.1007/BF00263903.
本文引用的文献
1
Hydroxyurea: differential lethal effects on cultured mammalian cells during the cell cycle.
Science. 1965 Dec 24;150(3704):1729-31. doi: 10.1126/science.150.3704.1729.
2
3
Cell killing studies on the mode of action of methotrexate on L-cells in vitro.
Cancer Res. 1969 Apr;29(4):737-44.
4
Some observations on the combined effects of x-rays and methotrexate on human tumor cells in vitro with possible relevance to their most useful combination in radiotherapy.
Am J Roentgenol Radium Ther Nucl Med. 1968 Mar;102(3):509-18. doi: 10.2214/ajr.102.3.509.
5
Carrier-mediated transport of the folic acid analogue, methotrexate, in the L1210 leukemia cell.
J Biol Chem. 1968 Oct 10;243(19):5007-17.
6
On the nature of permeability of sarcoma-180 cells to amethopterin in vitro.
Biochim Biophys Acta. 1965 May 25;102(1):210-25. doi: 10.1016/0926-6585(65)90214-1.
7
Progress report on high-dose methotrexate (NSC-740) with citrovorum rescue in the treatment of metastatic bone tumors.
Cancer Chemother Rep. 1974 Mar-Apr;58(2):275-80.
8
Phase I study of high doses of methotrexate with citrovorum factor in patients with lung cancer.
Cancer. 1972 Jul;30(1):22-30. doi: 10.1002/1097-0142(197207)30:1<22::aid-cncr2820300105>3.0.co;2-b.
9
Active transport of aminopterin in Yoshida sarcoma cells.
Biochim Biophys Acta. 1967;135(5):927-36. doi: 10.1016/0005-2736(67)90062-4.
10
An effective low-dose intermittent cyclophosphamide, methotrexate, and 5-fluorouracil treatment regimen for metastatic breast cancer.
Cancer. 1975 Apr;35(4):1101-7. doi: 10.1002/1097-0142(197504)35:4<1101::aid-cncr2820350413>3.0.co;2-m.
Zotero 插件